Compounds > 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid
Page last updated: 2024-10-21

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and Experimental High Pressure Neurological Syndrome

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with Experimental High Pressure Neurological Syndrome in 1 studies

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid: structure given in first source; NMDA receptor antagonist

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pearce, PC1
Halsey, MJ1
MacLean, CJ1
Ward, EM1
Webster, MT1
Luff, NP1
Pearson, J1
Charlett, A1
Meldrum, BS1

Other Studies

1 other study available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and Experimental High Pressure Neurological Syndrome

ArticleYear
The effects of the competitive NMDA receptor antagonist CPP on the high pressure neurological syndrome in a primate model.
    Neuropharmacology, 1991, Volume: 30, Issue:7

    Topics: Animals; Anticonvulsants; Atmospheric Pressure; Behavior, Animal; Electroencephalography; Female; Hi

1991